Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

Stopped early · Phase 1/Phase 2

Conditions studied: Cancer

In brief

The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.

Key facts

Study ID

NCT04106492

Run by

Shasqi, Inc.

People needed

53

Starts

2020-08-01

Expected to finish

2023-09-07

Last updated by the study team

2025-11-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• City of Hope — Duarte, California, United States
• Stanford Cancer Center — Palo Alto, California, United States
• Sarcoma Oncology Center — Santa Monica, California, United States
• Washington University in St. Louis — St Louis, Missouri, United States
• Oregon Health & Science University — Portland, Oregon, United States
• MD Anderson Cancer Center — Houston, Texas, United States
• University of Washington — Seattle, Washington, United States
• Chris O'Brien Lifehouse — Camperdown, New South Wales, Australia
• Royal North Shore Hospital — Sydney, New South Wales, Australia
• Cancer Research Institute — Adelaide, South Australia, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.